🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Whoops surgery of uterine sarcoma shouldn’t exist anymore!

Percutaneous biopsy of myometrial tumors identified on MRI is safe and effective sylvie bonvalot CTOS #CTOS2022 #CTOSTweeTOS OncoAlert #sarcoma Nat'l LMS Foundation

The 8 pillars of TARPSWG reunited in #Vancouver #CTOS2022 #CTOSTweeTOS From a small meeting in #Milan to the largest #retroperitoneal #sarcoma group of the world. What #leaders look like❗️

#5thMasterclass Debating: to treat or not to treat sts with neoadjuvant chemo.. sylvie bonvalot Sarah Watson

Learning a lot with Silvia Stacchiotti and sylvie bonvalot Hellenic Group of Sarcomas and rare tumors #sarcoma #gist meeting

Fantastic! Such an important achievement for ASPS patients and the #sarcoma community. A new era for immunotherapy in sarcoma is starting…. Silvia Stacchiotti Anna Maria Frezza Roberta Sanfilippo

"Initial Active Surveillance Strategy for Patients with Peripheral Sporadic Primary Desmoid-Type Fibromatosis: A Multicentric Phase II Observational Trial" (via #pubmedontap) ncbi.nlm.nih.gov/pubmed/37777684

LMS-04: ▫️DOX v DOX & trabectedin with ongoing TRAB ▫️Randomised ph3, n=150 #LMS ▫️Updated results at #ESMO23 ⭐️Improved PFS1, PFS2, OS ⭐️ ▪️RR before surg 13% v 36% 🔹more surgery in DOX+TRAB ▪️PFS 6.21 v 12.19m ▪️2 yr PFS 2.7 v 30.2% 🔸OS 23.78 v 33.08m 🔸2yr OS 49 v 69%

Excellent discussions on going in #sarcoma session on #hereditary and #genomicpredisposing syndromes at #ESMO23. Important considerations & emerging evidence of how these patients need #identified & #treated #differently. Professor DM Thomas sylvie bonvalot WinetteVanDerGraaf Tom Wei-Wu Chen

Surgical, med onc and rad onc perspectives on hereditary syndromes in #sarcoma by sylvie bonvalot WinetteVanDerGraaf Beate Timmerman Really excellent session, panel and discussions at #ESMO23🙏👏

🔶 Beyond study results, @Institut_Curie's physicians also share their expertise through Special Sessions at #ESMO23, as: ➡️ Prof. Anne Vincent-Salomon, discussing #ArtificialIntelligence in cancer prognosis ➡️ Prof. sylvie bonvalot, about treatment of sarcoma pts w/genetic predisposition

TARPSWG 10th yr anniversary. Who could have guessed back then how much we would have been able to achieve? Hundreds of members for multiple countries and 5 continents! And an observational study with thousands of pts in it! CTOS Society of Surgical Oncology European Society of Surgical Oncology (ESSO) EORTC

Very interesting - and persuasive- presentation by sylvie bonvalot Interestingly, numbers to define “high-volume” centers are tipically lower than would be anticipated #CTOS2023 CTOS

"Diagnostic accuracy and safety of percutaneous core needle biopsy of retroperitoneal tumours" (via #pubmedontap) ncbi.nlm.nih.gov/pubmed/38086314

Join us at #ESSO43 to hear the Lifetime Achievement Award lecture by sylvie bonvalot 🏆 🚨👉 Standard Registration rates until 4th Sep 🔗esso43.org

"Uterine sarcoma continues to be an area where preoperative diagnosis remains an unmet need today" by sylvie bonvalot #ESSO43 #OncoAlert ESGO European Network of Young Gynae Oncologists TARPSWG

The OncoAlert 🚨Coverage #ESSO43 DAY ONE Life Time Achievement Award Lecture🏆 Contributing to the enhancement of sarcoma patient care, a shared challenge for specialists across various disciplines Speaker: Dr. Sylvie Bonvalot🇫🇷 sylvie bonvalot All surgical specialists will

Sylvie Bonvalot received European Society of Surgical Oncology (ESSO) Life Time Achievement award #ESSO43 - an honour for all the #sarcomasurgery community. She has been a pioneer and lot of progress and change in last years has been developed on her input. Also proud of having the chance to learn from you Sylvie!

"Activation of lysosomal iron triggers ferroptosis in cancer" (via #pubmedontap) ncbi.nlm.nih.gov/pubmed/40335696

What is the primary cause of postoperative death after primary retroperitoneal sarcoma surgery in a high-volume center? A nationwide study by the French Sarcoma Group - European Journal of Surgical Oncology ejso.com/article/S0748-…